Your browser doesn't support javascript.
Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection.
Aryanian, Zeinab; Balighi, Kamran; Hatami, Parvaneh; Tootoonchi, Nasim Mazloumi; Goodarzi, Azadeh; Mohseni Afshar, Zeinab.
  • Aryanian Z; Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
  • Balighi K; Department of Dermatology Babol University of Medical Sciences Babol Iran.
  • Hatami P; Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
  • Tootoonchi NM; Department of Dermatology Razi Hospital Tehran University of Medical Sciences Tehran Iran.
  • Goodarzi A; Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
  • Mohseni Afshar Z; Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
Clin Case Rep ; 10(4): e05667, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1797957
ABSTRACT
Although the presence of morphea following COVID-19 has been rarely reported, the development of its generalized form following COVID-19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID-19 vaccination and another similar case following SARS-Cov-2 infection. Other etiologic factors were also dealt with.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Etiology study Topics: Vaccines Language: English Journal: Clin Case Rep Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Etiology study Topics: Vaccines Language: English Journal: Clin Case Rep Year: 2022 Document Type: Article